Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Burgstahler Insider Profile
4 Followers
David Burgstahler, Director at AngioDynamics, holds 16.76M shares in Osmotica Pharmaceuticals (Ticker: OSMT), holds 35.39K shares in Wideopenwest (Ticker: WOW), holds 17.79M shares in Lantheus (Ticker: LNTH).
Profitable Transactions
9 out of 15 Profitable Transactions
Average Return
+0.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Burgstahler holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Burgstahler
David Burgstahler's Trading History
AngioDynamics
Apr 14, 2017
Director
Informative Sell
37.60M
$135.73M
Lantheus
Sep 11, 2017
Director
Informative Sell
1.70M
$234.34M
Wideopenwest
Jan 10, 2018
Director
Uninformative Buy
―
$288.05K
Osmotica Pharmaceuticals
Nov 23, 2020
Director, Ten Percent Owner
Uninformative Sell
―
$102.59M
Syneos Health
May 24, 2017
Director, Ten Percent Owner
Uninformative Buy
―
$1.73B
Warner Chilcott
―
―
―
―
List of latest transactions for each holding click on a transaction to see David Burgstahler's performance on stock
You May Also Like
David Burgstahler insider profile FAQ
What is the percentage of profitable transactions made by David Burgstahler?
The percentage of profitable transactions made by David Burgstahler is 60%.
What is the average return per transaction made by David Burgstahler?
The average return per transaction made by David Burgstahler is 0.90%.
What stocks does David Burgstahler hold?
David Burgstahler holds: ANGO, LNTH, WOW, OSMT, SYNH, WCRX stocks.
What was David Burgstahler’s latest transaction?
David Burgstahler latest transaction was an Uninformative Sell of ―.
What was David Burgstahler's most profitable transaction?
David Burgstahler’s most profitable transaction was an Informative Buy of SYNH stock on November 6, 2014. The return on the trade was 137.90%.
What is David Burgstahler's role in AngioDynamics?
David Burgstahler's role in AngioDynamics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.